Adheron Therapeutics' Convertible Note Round

Adheron Therapeutics raised a round of funding on July 31, 2015.

Adheron Therapeutics, formerly Synovex, is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases. The target is Cadherin 11, a …

Articles about Adheron Therapeutics' Convertible Note Round: